Risk of death or reinfarction associated with the use of selective cyclooxygenase-2 inhibitors and nonselective nonsteroidal antiinflammatory drugs after acute myocardial infarction.

Gislason, Gunnar H; Jacobsen, Søren; Rasmussen, Jeppe N; Rasmussen, Søren; Buch, Pernille; Friberg, Jens; Schramm, Tina Ken; Abildstrom, Steen Z; Køber, Lars; Madsen, Mette; Torp-Pedersen, Christian

Gislason, Gunnar H; Jacobsen, Søren; Rasmussen, Jeppe N; Rasmussen, Søren; Buch, Pernille; Friberg, Jens; Schramm, Tina Ken; Abildstrom, Steen Z; Køber, Lars; Madsen, Mette; Torp-Pedersen, Christian.

Affiliation

Gislason GH; Department of Cardiology, Gentofte University Hospital, DK-2900 Hellerup, Denmark. gg@heart.dk

Circulation ; 113(25): 2906-13, 2006 Jun 27.

Article in En | MEDLINE | ID: mdl-16785336

Subject(s)

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Anti-Inflammatory Agents, Non-Steroidal / Cyclooxygenase 2 Inhibitors / Myocardial Infarction Type of study: Etiology_studies / Evaluation_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged80 Country/Region as subject: Europa Language: En Journal: Circulation Year: 2006 Document type: Article Affiliation country: Dinamarca

Search on Google

Add to My VHL

XML

PubMed Links